An examination of biopharma company CEO salaries shows that many are paid like a hybrid of entrepreneurs and blue chip company CEOs, giving these executives the best of both worlds.
They may not be running too big to fail firms, but the CEOs of many small biopharmaceutical companies are being paid like they are unquestionably indispensable, In fact, many are making more than Wall Street’s chief executives and the CEOs of their much larger pharmaceutical peers.
Read the rest here.
No comments:
Post a Comment